Skip navigation

Refine by Type

Results 1 - 10 of 18 for RANIBIZUMAB
  1. Ranibizumab is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye ... to read, drive, or perform other daily activities). Ranibizumab is in a class of medications called vascular ...
  2. ... Drug Administration (FDA) approved a promising new drug—ranibizumab (marketed as Lucentis) — for treatment of neovascular agerelated ... second drug is considerably cheaper for patients than ranibizumab. "The good news for patients is that there ...
  3. Clinical Trials for Dry AMD (Macular Degeneration Partnership)  
    ... Lucentis For Dry AMD The clinical trial, Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (PREVENT) is ... The study will determine whether quarterly injections of Ranibizumab (Lucentis) may prevent eyes with dry AMD from ...
  4. If I Had - Macular Degeneration Video (Insidermedicine)  
    ... well. There’s several drugs that are out there – ranibizumab was tested in large clinical trials and showed ...
  5. Foundation Fighting Blindness (Foundation Fighting Blindness)  
    ... change for leading sight loss treatment Lucentis® (ranibizumab) New scheme to raise sight loss awareness in ...
  6. ... which are injected into the eye, are Lucentis (ranibizumab) and Avastin (bevacizumab). Results indicate that the two ...
  7. Retinoschisis (Juvenile) (Foundation Fighting Blindness)  
    ... change for leading sight loss treatment Lucentis® (ranibizumab) New scheme to raise sight loss awareness in ...
  8. ... which are injected into the eye, are Lucentis (ranibizumab) and Avastin (bevacizumab). NEI is also supporting AREDS2 ...
  9. Bardet-Biedl Syndrome (Foundation Fighting Blindness)  
    ... change for leading sight loss treatment Lucentis® (ranibizumab) New scheme to raise sight loss awareness in ...
  10. ... this alarming statistic. What's New: Two new drugs, ranibizumab (Lucentis) and bevacizumab (Avastin) are being used to ...
previous · 1 · 2 · next